Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

The DDR1 receptor tyrosine kinase is activated by matrix collagens and has been implicated in numerous cellular functions such as proliferation, differentiation, adhesion, migration, and invasion. Here we report the discovery of a potent and selective DDR1 inhibitor, DDR1-IN-1, and present the 2.2 Å...

Полное описание

Библиографические подробности
Главные авторы:	Kim, H, Tan, L, Weisberg, E, Liu, F, Canning, P, Choi, H, Ezell, SA, Wu, H, Zhao, Z, Wang, J, Mandinova, A, Griffin, J, Bullock, A, Liu, Q, Lee, S, Gray, N
Формат:	Journal article
Язык:	English
Опубликовано:	2013

Схожие документы

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.
по: Kim, H, и др.
Опубликовано: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors
по: Canning, P, и др.
Опубликовано: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
по: Canning, P, и др.
Опубликовано: (2014)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
по: Maria G. Nava, и др.
Опубликовано: (2023-02-01)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
по: López-Ramos, M, и др.
Опубликовано: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
по: López-Ramos, M, и др.
Опубликовано: (2010)

Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
по: William A. Denny, и др.
Опубликовано: (2021-11-01)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
по: Panupong Mahalapbutr, и др.
Опубликовано: (2024-02-01)

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling
по: Ronnakorn Leechaisit, и др.
Опубликовано: (2023-08-01)

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
по: Patrice Dubreuil, и др.
Опубликовано: (2009-09-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
по: Xu H, и др.
Опубликовано: (2019-07-01)

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
по: Sudarshan R Iyer, и др.
Опубликовано: (2023-10-01)

Recent Advances in Discovery of New Tyrosine Kinase Inhibitors Using Computational Methods
по: Vesna Rastija
Опубликовано: (2019-08-01)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
по: Chunmin Yang, и др.
Опубликовано: (2022-05-01)

Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.
по: Hellwig, S, и др.
Опубликовано: (2012)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
по: Lopez-Ramos, M, и др.
Опубликовано: (2011)

Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1
по: C. Reger de Moura, и др.
Опубликовано: (2024-01-01)

Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells.
по: Ellen Weisberg, и др.
Опубликовано: (2013-01-01)

First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2
по: Ian M. Catlett, и др.
Опубликовано: (2023-01-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
по: Maria Dimou, и др.
Опубликовано: (2014-01-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
по: Elisabetta Abruzzese, и др.
Опубликовано: (2014-04-01)

Second-generation inhibitors of Bruton tyrosine kinase
по: Jingjing Wu, и др.
Опубликовано: (2016-09-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
по: Cornelius Hempel, и др.
Опубликовано: (2017-01-01)

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents
по: Yangyang Yao, и др.
Опубликовано: (2017-10-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
по: John J. Ryan, MD
Опубликовано: (2016-12-01)

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?
по: Zhao, Z, и др.
Опубликовано: (2014)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
по: Ainun Nizar Masbuchin, и др.
Опубликовано: (2022-09-01)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
по: G. V. Lukina, и др.
Опубликовано: (2015-12-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
по: Huang JT, и др.
Опубликовано: (2022-11-01)

Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
по: Mark C Weir, и др.
Опубликовано: (2017-01-01)

miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors
по: Tatsuki Shibuta, и др.
Опубликовано: (2022-06-01)

Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
по: Chris Liang, и др.
Опубликовано: (2022-03-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
по: Jiangnan Liu, и др.
Опубликовано: (2024-03-01)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
по: Wu J, и др.
Опубликовано: (2020-09-01)

Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders
по: Muhammad Waleed Iqbal, и др.
Опубликовано: (2025-01-01)

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
по: Pitsiou G, и др.
Опубликовано: (2014-10-01)

509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer
по: Matthew Walters, и др.
Опубликовано: (2020-11-01)

Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma
по: Wei Dai, и др.
Опубликовано: (2021-05-01)

Tetrahydroisoquinoline-7-carboxamide derivatives as new selective discoidin domain receptor 1 (DDR1) inhibitors
по: Bullock, A, и др.
Опубликовано: (2017)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
по: Evan Pisick, и др.
Опубликовано: (2004-01-01)